Re: At time of conversion
|
|
BIOASIS TECHNOLOGIES INC
|
Dec 15, 2022 06:17PM
|
Re: 75,000 cross trade by the look of things...
|
|
Resverlogix Corp.
|
Feb 06, 2020 10:42AM
|
Re: I called E trade this morning 10/20/2020
|
|
Zenith Epigenetics
|
Oct 20, 2020 10:39AM
|
Re: Sneaking Suspicion...
|
|
Resverlogix Corp.
|
Feb 04, 2021 04:39PM
|
Re: Trial
|
|
Resverlogix Corp.
|
May 25, 2021 09:00AM
|
Re: Total Shares Outstanding 10/15/20
|
|
Resverlogix Corp.
|
Oct 15, 2020 04:27PM
|
Re: Amarin 3 or 5 point MACE
|
|
Resverlogix Corp.
|
Feb 13, 2019 09:24AM
|
Re: BETonMACE Placebo Estimate
|
|
Resverlogix Corp.
|
Feb 23, 2019 12:04PM
|
Re: Short Call
|
|
Resverlogix Corp.
|
Sep 06, 2018 03:25PM
|
Re: TNBC Competition
|
|
Zenith Epigenetics
|
Feb 20, 2023 03:32PM
|
Re: A Special Meeting of Shareholders?
|
|
Resverlogix Corp.
|
May 30, 2024 02:42PM
|
Re: Is anyone else seeing 0 lots available on the ask at $1.07?
|
|
Resverlogix Corp.
|
Mar 27, 2020 12:56PM
|
Re: RVV insider purchases
|
|
Resverlogix Corp.
|
Dec 13, 2022 10:04AM
|
Re: BTI press release
|
|
BIOASIS TECHNOLOGIES INC
|
Jun 26, 2021 04:14AM
|
Re: Breakthrough Designation
|
|
Resverlogix Corp.
|
May 28, 2020 12:52PM
|
(Newsfile Corp. - July 16, 2024)
|
|
Resverlogix Corp.
|
Jul 16, 2024 07:24AM
|
Re: Zenith Epigenetics Announces Start of Several National Cancer Institute (NCI)-Sponsored Oncology Clinical Trials
|
|
Zenith Epigenetics
|
Jul 07, 2022 12:25PM
|
Re: Some history
|
|
Resverlogix Corp.
|
Feb 01, 2023 08:19AM
|
Re: BTI press release
|
|
BIOASIS TECHNOLOGIES INC
|
Jun 26, 2021 10:28AM
|
Re: "Actively Recruiting" ?
|
|
Resverlogix Corp.
|
Nov 04, 2021 10:58AM
|